Towards a combined prognostic index for survival in HIV infection: the role of non-HIV biomarkers

HIV Medicine, 09/16/2009

When added to HIV biomarkers, 'non–HIV' biomarkers improve differentiation of mortality. When evaluated over similar intervals, the VACS Index discriminates as well as other established indices. After further validation, the VACS Index may provide a useful, integrated risk assessment for management and research.

Print Article Summary Cat 2 CME Report